Evidence Gaps

Summary of findings: insulin detemir vs NPH insulin

(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 3122 participants
Moderate

(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes… 2020 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 2233 participants
Low

Summary of findings: insulin detemir vs insulin glargine

(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 763 participants
Low

Summary of findings: insulin detemir vs Insulin glargin (control)

Insulin detemir versus insulin glargine for type 2 diabetes mellitus 2011 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 2250 participants
Low